Are you a patient?
Please visit our patient website for more information on cataract treatment:
Just two steps for easy and intuitive injector preparation.
Benefit from ZEISS state-of-the-art OVD portfolio that supports you at each step of your monofocal cataract procedure.
The lens was very stable in the bag from the first week after surgery
This newly available experience kit has been developed to provide a unique way to discover two products at the same time: ZEISS miLOOP and ZEISS CT LUCIA 621PY.
After registration your local ZEISS representative will be in touch to arrange a convenient date to demo the kit either digital or in person.
Please note: The ZEISS CT LUCIA & ZEISS miLOOP drylab kit demo session is only available in the following countries: Argentina, Australia, Austria, Belgium, Bolivia, Brazil, Chile, Costa Rica, Denmark, Dominican Republic, Ecuador, El Salvador, Finland, France, Germany, Hungary, Ireland, Italy, Luxembourg, Malaysia, Mexico, Netherlands, New Zealand, Norway, Peru, Portugal, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Thailand, UAE, UK, Vietnam.
CT LUCIA® 621P/PY is the recently enhanced monofocal, hydrophobic, C-Loop IOL from ZEISS, which allows you to treat a wide range of patients with a unique ZEISS Optic, featuring:
The miLOOP® from ZEISS is a game-changing microinterventional lens fragmentation device, which is designed to remove the challenges of hard cataracts.
Several benefits of a preloaded IOL during intraoperative handling were detected, when implanting the CT LUCIA as one of two IOLs used in a recent comparative study.
Shorter unfolding times, easier handling and faster centration during IOL delivery, are some of the advantages noticed during this clinical trial.
The features of the CT LUCIA 621P IOL, including its intraoperative handling characteristics, excellent refractive predictability, stability in the capsular bag, and consistently good visual outcomes, make it a good option to use as our standard IOL for cataract surgery patients with a monofocal lens.
Our industry leading portfolio connects the cataract workflow – from office to OR and back. Learn how you can achieve efficiency without compromise for your full cataract procedure with ZEISS.
The data is taken from a simulation. The transferability of the results of such a simulation to patients with an actual implanted intraocular lenses has not yet been scientifically proven. Whether the simulated impressions correspond to the actual visual impressions must be clarified in future invasive studies.
Ianchulev T, Chang DF, Koo E, et al Microinterventional endocapsular nucleus disassembly: novel technique and results of first-in-human randomised controlled study. British Journal of Ophthalmology April 2018.
The majority of trained ZEISS miLOOP surgeons report a perceived reduction in overall procedure time (internal user survey, n=279, Iantech Data Analytics 20190708 PPT, data on file). Furthermore, ZEISS miLOOP usually results less trauma to capsular bag and zonules (see source 2) thereby potentially reducing the need for additional post-operative treatment (see source 4). Additionally, ZEISS miLOOP may reduce the likelihood of needing time-consuming post-operative treatments: One of major causes for endothelial cell loss in cataracts with increased density is the amount of phaco energy emitted into the eye during surgery (see sources 5,6,7,8,9). Thus, the ability to significantly reduce the overall phaco power by using ZEISS miLOOP (see source 2) may decrease the number of related complications that need post-operative treatments.
Wont T et al, Phacoemulsification time and power requirements in phaco chop and divide and conquer nucleofractis techniques – J Cataract Refract Surg 2000; 26:1374-1378
Soliman M et al, Relationship between endothelial cell loss and micro coaxial phacoemulsification parameters in noncomplicated cataract surgery – Clinical Ophthalmology 2012:6 503-510
Pirazzoli G. et al, Effects of phacoemulsification time on the corneal endothelium using phacofracture and phaco chop techniques – J Cataract Refract Surg Vol 22, Sept 1996
O’Brien Paul D. et al, Risk factors for endothelial cell loss after phacoemulsification surgery by a junior resident – J Cataract Refract Surg 2004; 30:839-843
Hwang H B et al, Endothelial Cell Loss after Phacoemulsification according to Different Anterior Chamber Depths – Journal of Ophthalmology Vol 2015, Article ID 210716
Park J et al, Comparison of phaco-chop, divide-and-conquer, and stop-and-chop phaco techniques in microincision coaxial cataract surgery – J Cataract Refract Surg 2013; 39:1463-1469